Integration of Novel Antibody–Drug Conjugates in Advanced HER2-Low, Hormone Receptor–Positive, and Triple-Negative Breast Cancer

Content Format:

PDF

Credit Type:

--

Credits:

--
Comparison of expert treatment recommendations vs community healthcare providers: analysis from an online decision support tool for metastatic breast cancer

Content Format:

PDF

Credit Type:

--

Credits:

--
TROP-2–Targeted Therapy: Redefining the Therapeutic Landscape in HER2-Negative Breast Cancer

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
TROP-2–Targeted Therapy: Redefining the Therapeutic Landscape in HER2-Negative Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Optimizing Outcomes and Quality of Life for Patients With Advanced Breast Cancer Through Effective Management of ADC-Associated Toxicities

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Optimizing Outcomes and Quality of Life for Patients With Advanced Breast Cancer Through Effective Management of ADC-Associated Toxicities

Content Format:

Slideset

Credit Type:

--

Credits:

--
Making Treatment Decisions for Metastatic Breast Cancer: An Interactive Decision Support Tool for Patients

Content Format:

Tool

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: Expert Treatment Guidance for Metastatic Breast Cancer

Content Format:

Tool

Credit Type:

--

Credits:

--
How I Apply New Clinical Developments to the Management of Metastatic Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Evening With the Experts: Discussing the Rapidly Evolving Treatment Landscape for Early-Stage Breast Cancer

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
Evaluating and Managing High-Risk Disease in HR+/HER2- EBC (Without gBRCA)

Content Format:

Slideset

Credit Type:

--

Credits:

--
Frequently Asked Questions: Expanding the Spectrum of HER2 Positivity in Advanced Breast Cancer With T-DXd

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expanding the Spectrum of HER2 Positivity for Precision Breast Cancer Care: Clinical Implications of HER2-Low Status

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
ExpressPoints Expanding the Spectrum of HER2 Positivity for Precision Breast Cancer Care: Clinical Implications of HER2-Low Status

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Expanding the Spectrum of HER2 Positivity for Precision Breast Cancer Care: Clinical Implications of HER2-Low Status

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: HER2-Positive Metastatic Breast Cancer Expert Guidance

Content Format:

Tool

Credit Type:

--

Credits:

--
Podcast Pearls: HER2-Positive Breast Cancer: Current Approaches for Quality Care

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
HER2-Positive Breast Cancer: Current Approaches for Quality Care

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Key Updates in the Treatment of Hormone Receptor–Positive Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expanding the Scope of Precision Care for Patients With HR-Positive Breast Cancers: Things You Should Know

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Selection and Sequencing of Targeted Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Assessing Risk and Individualizing Therapy in HR+/HER2- Early Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Practical Management of Adverse Events and Strategies to Promote Adherence with Targeted Therapies in HR-Positive Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--